T/GMIAAC 002-2023 Active Group standards

T/GMIAAC 002-2023 Type 2 diabetes mellitus intensified management, reversal, and remission standards and technical specifications

T/GMIAAC 002-2023 Type 2 diabetes mellitus intensified management, reversal, and remission standards and technical specifications

Publish Date: 2022-05-09 Implement Date: 2023-05-09 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 31.00
Out of stock

Basic Information

Standard Code: T/GMIAAC 002-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Urban transportation facilities
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2022-05-09
Implement Date: 2023-05-09
Pages: 20 pages

Scope

This document specifies the treatment mechanisms, evaluation methods, management principles, and behavioral interventions for the enhanced management, reversal, and alleviation of type 2 diabetes, as well as follow-up and reassessment, and intervention measures.
This document is applicable to endocrinology departments or diabetes specialty clinics in specialized wards, outpatient clinics, community health centers, and social institutions. Internal medicine departments can refer to and use it for reference.

Development Information

Word Count: 37 Thousand words Pages: 20 pages

Related Standards

Contact Us